Home > National Drug Code (NDC) > Novolin70/30

Novolin70/30 - 52125-414-01 - (Human Insulin)

Alphabetical Index


Drug Information of Novolin70/30

Product NDC: 52125-414
Proprietary Name: Novolin70/30
Non Proprietary Name: Human Insulin
Active Ingredient(s): 100    [USP'U]/mL & nbsp;   Human Insulin
Administration Route(s): SUBCUTANEOUS
Dosage Form(s): INJECTION, SUSPENSION
Coding System: National Drug Codes(NDC)

Labeler Information of Novolin70/30

Product NDC: 52125-414
Labeler Name: REMEDYREPACK INC.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA019991
Marketing Category: NDA
Start Marketing Date: 20130613

Package Information of Novolin70/30

Package NDC: 52125-414-01
Package Description: 10 mL in 1 VIAL (52125-414-01)

NDC Information of Novolin70/30

NDC Code 52125-414-01
Proprietary Name Novolin70/30
Package Description 10 mL in 1 VIAL (52125-414-01)
Product NDC 52125-414
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Human Insulin
Dosage Form Name INJECTION, SUSPENSION
Route Name SUBCUTANEOUS
Start Marketing Date 20130613
Marketing Category Name NDA
Labeler Name REMEDYREPACK INC.
Substance Name INSULIN HUMAN
Strength Number 100
Strength Unit [USP'U]/mL
Pharmaceutical Classes Insulin [Chemical/Ingredient],Insulin [EPC]

Complete Information of Novolin70/30


General Information